univasc — Class II drug recall D-1348-2015
Terminated recall by Ucb, Inc, reported 2015-08-26, distributed nationwide. Failed Dissolution Testing: Failed 24 month dissolution testing.
| Recall number | D-1348-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Ucb, Inc, Smyrna, GA, United States |
| Recall initiated | 2015-07-24 |
| Classified | 2015-08-19 |
| Reported by FDA | 2015-08-26 |
| Terminated | 2017-07-19 |
| Distributed | Nationwide (US) |
| Quantity | 2,916 bottles |
| Reason classes | specification failure |
| NDC | 00091-3707-01 |
| Lot numbers | 98016P1 |
Product
univasc (moexipril HCl) tablets, 7.5 mg, 100 Ct Bottle, Rx Only. Manufactured for UCB, Inc., Smyrna, GA 30080. NDC: 0091-3707-01.
Reason for recall
Failed Dissolution Testing: Failed 24 month dissolution testing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1348-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.